TY  - GEN
AU  - Liu,Shuzhen
AU  - Chen,Bingshu
AU  - Burugu,Samantha
AU  - Leung,Samuel
AU  - Gao,Dongxia
AU  - Virk,Shakeel
AU  - Kos,Zuzana
AU  - Parulekar,Wendy R
AU  - Shepherd,Lois
AU  - Gelmon,Karen A
AU  - Nielsen,Torsten O
TI  - Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
SN  - 2374-2445
PY  - 2017///1120
KW  - Aged
KW  - Antineoplastic Agents, Immunological
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Clinical Trials, Phase III as Topic
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lapatinib
KW  - Lymphocytes, Tumor-Infiltrating
KW  - immunology
KW  - Middle Aged
KW  - Multicenter Studies as Topic
KW  - Multivariate Analysis
KW  - Neoplasm Metastasis
KW  - Paclitaxel
KW  - Patient Selection
KW  - Predictive Value of Tests
KW  - Proportional Hazards Models
KW  - Prospective Studies
KW  - Protein Kinase Inhibitors
KW  - Quinazolines
KW  - Randomized Controlled Trials as Topic
KW  - Receptor, ErbB-2
KW  - Retrospective Studies
KW  - T-Lymphocytes, Cytotoxic
KW  - Taxoids
KW  - Time Factors
KW  - Trastuzumab
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1001/jamaoncol.2017.2085
ER  -